Protective immune responses against West Nile virus are primed by distinct complement activation pathways.

["Mehlhop E", "Diamond M"]
The Journal of experimental medicine 2006
Open on PubMed

West Nile virus (WNV) causes a severe infection of the central nervous system in several vertebrate animals including humans. Prior studies have shown that complement plays a critical role in controlling WNV infection in complement (C) 3(-/-) and complement receptor 1/2(-/-) mice. Here, we dissect the contributions of the individual complement activation pathways to the protection from WNV disease. Genetic deficiencies in C1q, C4, factor B, or factor D all resulted in increased mortality in mice, suggesting that all activation pathways function together to limit WNV spread. In the absence of alternative pathway complement activation, WNV disseminated into the central nervous system at earlier times and was associated with reduced CD8+ T cell responses yet near normal anti-WNV antibody profiles. Animals lacking the classical and lectin pathways had deficits in both B and T cell responses to WNV. Finally, and somewhat surprisingly, C1q was required for productive infection in the spleen but not for development of adaptive immune responses after WNV infection. Our results suggest that individual pathways of complement activation control WNV infection by priming adaptive immune responses through distinct mechanisms.

7 Figures Extracted
Figure 1.
Figure 1. PMC
Complement is activated in vivo in response to WNV infection. Levels of functional (A) C3 and (B) C4 were determined by erythrocyte hemolysis assay o...
Figure 3.
Figure 3. PMC
WNV infection in serum and lymphoid tissues. WNV RNA levels in the serum (A), spleen (C), and draining inguinal lymph node (D) of wild-type, C1q −/− ...
Figure 2.
Figure 2. PMC
All pathways of complement activation are required for survival of WNV infection. Wild-type ( n = 95), C1q −/− ( n = 60), C4 −/− ( n = 34), fD −...
Figure 4.
Figure 4. PMC
WNV infection in CNS tissues. Infectious WNV burden in (A) spinal cord and (C) brain from wild-type, C1q −/− , C4 −/− , fD −/− , and fB −/− mice was...
Figure 5.
Figure 5. PMC
WNV antigen staining in the brain. The brains of wild-type, C1q −/− , C4 −/− , and fD −/− mice were harvested on day 10, sectioned, and stained for ...
Figure 6.
Figure 6. PMC
Humoral responses against WNV. Serum samples from wild-type, C1q −/− , C4 −/− , fD −/− , and fB −/− mice were collected at the indicated time points...
Figure 7.
Figure 7. PMC
T cell activation and trafficking after WNV infection. (A) Mock or WNV-infected splenocytes from wild-type, C1q −/− , C4 −/− , fD −/− , and fB −/− m...